Erin D. Michos, MD, MHS

home / authors / erin-d-michos-md-mhs

Articles

DCRM Practice Recommendations for ASCVD and Metabolic Diseases

Yehuda Handelsman, MD;Matthew J. Budoff, MD;Christie Ballantyne, MD;Erin D. Michos, MD, MHS;Paul S. Jellinger, MD, MACE

May 9th 2022

Expert endocrinologists and cardiologists review the role of DCRM multispecialty practice recommendations and the use of combination therapy for patients with ASCVD and hypercholesterolemia.

Utilizing Guideline Recommendations for ASCVD and Hypercholesterolemia Management

Yehuda Handelsman, MD;Matthew J. Budoff, MD;Christie Ballantyne, MD;Erin D. Michos, MD, MHS;Paul S. Jellinger, MD, MACE

May 2nd 2022

Drs Erin D. Michos, Matthew J. Budoff, Paul S. Jellinger, and Yehuda Handelsman, share their approach to incorporating guideline recommendations for the management of patients with ASCVD and hypercholesterolemia in clinical practice.

Management of Patients With ASCVD and Hypercholesterolemia

Yehuda Handelsman, MD;Matthew J. Budoff, MD;Christie Ballantyne, MD;Erin D. Michos, MD, MHS;Paul S. Jellinger, MD, MACE

May 2nd 2022

Dr Christie Ballantyne leads a discussion on how the management of patients with ASCVD and hypercholesterolemia has changed over the years.

Impact of Comorbidities on Atherosclerosis

Yehuda Handelsman, MD;Matthew J. Budoff, MD;Christie Ballantyne, MD;Erin D. Michos, MD, MHS;Paul S. Jellinger, MD, MACE

April 25th 2022

Yehuda Handelsman, MD; Christie Ballantyne, MD; Paul S. Jellinger, MD, MACE; and Erin D. Michos, MD, MHS, comment on the impact of diabetes on chronic kidney disease and cardiovascular disease.

Prevalence and Risk Factors for ASCVD Associated With Hypercholesterolemia

Yehuda Handelsman, MD;Matthew J. Budoff, MD;Christie Ballantyne, MD;Erin D. Michos, MD, MHS;Paul S. Jellinger, MD, MACE

April 25th 2022

Matthew J. Budoff, MD; Christie Ballantyne, MD; and Paul S. Jellinger, MD, MACE, discuss the incidence and prevalence of atherosclerotic cardiovascular diseases (ASCVD) associated with hypercholesterolemia and risk factors for disease.

<1 2 3